UCB - PE Price to Earnings


UCB reported 29.7 in PE Price to Earnings for its fiscal semester ending in December of 2025.





Pe Change Date
Alcon AG 38.19 3.79 Dec/2025
Almirall 79.43 0.3 Dec/2025
Amarin 91.05 88.3 Jun/2023
argenx SE 43.02 11.67 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bayer 5.93 0.68 Sep/2025
Galapagos 3.14 50.78 Dec/2025
Genmab 17.14 4.39 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
GRIFOLS 16.81 28.19 Sep/2025
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lonza 34.34 2.58 Dec/2025
Merck 20.56 7.18 Dec/2025
Novartis 17.85 2.11 Dec/2025
Orion 28.54 2.43 Dec/2025
Recordati 25.3 1.41 Sep/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
UCB 29.7 5.52 Dec/2025
Unibail Rodamco 10.36 0.43 Dec/2025